Revert the SIRT: Normalizing SIRT1 Activity in Myelodysplastic Stem Cells.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 30193128.
- Also identified by DOI 10.1016/j.stem.2018.08.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Myelodysplastic syndromes are hematologic malignancies with few treatment options and a propensity to transform to acute myeloid leukemia. In this issue of Cell Stem Cell, Sun et al. (2018) report that low SIRT1 levels in myelodysplastic stem cells contribute to aberrant self-renewal through enabling hyperacetylation and reduced activity of TET2.
Medical subject headings
- Hematologic Neoplasms
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes